Sign In
Buy LJPC
$6.22
+0 (+0%)
At Close: Jan 27, 2023
Protagonist Therapeutics: Robust Polycythemia Vera Data Is Just The Beginning (NASDAQ:PTGX)
04:22pm, Wednesday, 10'th Jun 2020
Protagonist Therapeutics' PTG-300 could become a new standard of care in Polycythemia Vera (PV). The market opportunity for PTG-300 in PV is underappreciated; i
Monday’s small-cap stocks to watch
12:49pm, Monday, 08'th Jun 2020
Our roundup of Canadian small-caps of between $100-million and $2.5-billion in market capitalization making news and on the move today
Insider Weekends: A Large Sale By The CEO Of An Airline
12:29pm, Monday, 08'th Jun 2020
Insider buying decreased last week. Notable Insider Buys: Danaher Corporation, Avid Technology, Inc., Allogene Therapeutics, Inc., La Jolla Pharmaceutical Compa
Call for zero rate VAT as stores reopen; CRH US subsidiary accused of discrimination
05:30am, Monday, 08'th Jun 2020
Business Today: the best news, analysis and comment from The Irish Times business desk
CRH subsidiary agrees settlement after alleged discrimination
02:15am, Monday, 08'th Jun 2020
US-subsidiary alleged to have discriminated against female, African American applicants
Up-to-date arrangements save tears and costs
11:51pm, Wednesday, 03'rd Jun 2020
Preparing for death or dementia isn't pleasant, but taking a few early steps can stop a lot of angst later on.
5 New Houses Foreclosed In The San Diego Area
10:35pm, Saturday, 30'th May 2020
Check out the newest foreclosed properties up for sale near you.
Global Sickle Cell Disease Clinical Trial Pipeline Highlights 2020 - ResearchAndMarkets.com
12:00am, Friday, 29'th May 2020
The
US election could spell trouble for Irish economic model
07:00pm, Friday, 22'nd May 2020
America Letter: Desire to ‘repatriate’ jobs is a rare issue Trump and Biden agree on
Hong Kong tensions unnerve world stocks
05:25pm, Friday, 22'nd May 2020
China’s plan to impose new security law on Hong Kong rattles markets
AcelRx Pharmaceuticals: Lean Back And Watch The Rocket Launch (NASDAQ:ACRX)
05:01pm, Friday, 22'nd May 2020
ACRX confirmed final agreement with its cornerstone client, the US Army. Sales from DSUVIA still need to pick up. But reports from doctors using DSUVIA on their
